Matinas Biopharma Holdings Inc (MTNB)

[stocktrademan]

$MTNB recent news/filings

bullish

## source: finance.yahoo.com

Tue, 07 Apr 2015 12:05:00 GMT ~ Matinas BioPharma to Present at the 2nd Annual Growth Capital Expo on April 13, 2015

[GlobeNewswire] - BEDMINSTER, N.J. -- Matinas BioPharma Holdings, Inc. ("Matinas BioPharma" or the "Company") (OTCQB:MTNB), a clinical-stage biopharmaceutical company focused on the development and commercialization ...

read full: http://finance.yahoo.com/news/matinas-biopharma-present-2nd-annual-120500988.html
*********************************************************

Mon, 06 Apr 2015 20:17:51 GMT ~ MATINAS BIOPHARMA HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of


read full: http://biz.yahoo.com/e/150406/mtnb8-k.html
*********************************************************

Sat, 04 Apr 2015 17:04:14 GMT ~ MATINAS BIOPHARMA HOLDINGS, INC. Financials


read full: http://finance.yahoo.com/q/is?s=mtnb
*********************************************************

Tue, 31 Mar 2015 10:21:56 GMT ~ MATINAS BIOPHARMA HOLDINGS, INC. Files SEC form 10-K, Annual Report


read full: http://biz.yahoo.com/e/150331/mtnb10-k.html
*********************************************************

Mon, 30 Mar 2015 12:05:00 GMT ~ Matinas BioPharma Completes Enrollment in First Human Trial of MAT9001

[GlobeNewswire] - -- Study Steering Committee Recommends Early Completion of Enrollment Due to Adequate Power in Study to Demonstrate Study Endpoints -- -- Top-line Data Expected to be Reported in Second Quarter 2015 --...

read full: http://finance.yahoo.com/news/matinas-biopharma-completes-enrollment-first-120500247.html
*********************************************************

$MTNB charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$MTNB company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/MTNB/company-info
Ticker: $MTNB
OTC Market Place: OTCQB
CIK code: 0001582554
Company name: Matinas Biopharma Holdings, Inc.
Company website: http://www.matinasbiopharma.com
Incorporated In: DE, USA

Business Description: Matinas BioPharma is a clinical stage biopharmaceutical company, founded in 2011, focused on the development of targeted therapeutics using our innovative lipid-based drug delivery platform with an initial focus on the treatment of serious fungal and bacterial infections and the development of lipid-based prescription therapeutics for the treatment of cardiovascular and metabolic conditions. We are focused on creating highly differentiated, safe and efficacious therapies utilizing our expertise in drug formulation and development in order to address significant unmet medical needs. Recent additions to our product pipeline, including MAT2203 and MAT2501, position Matinas BioPharma to become a leader in the safe and effective delivery of anti-infective therapies utilizing its proprietary lipid-crystal nano-particle cochleate formulations. We also continue to develop our cardiovascular therapeutic candidates, with a focus on completing our ongoing PK/PD study with MAT9001, which has the goal of determining superior bioavailability and enhanced efficacy over a leading therapy for hypertriglyceridemia, as well as developing a product candidate resulting from our MAT8800 discovery program for the treatment of non-alcoholic fatty liver disease. For more information, please visit www.matinasbiopharma.comLess >>


$MTNB share structure

## source: otcmarkets.com

Market Value: $29,520,536 a/o Apr 08, 2015
Shares Outstanding: l PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">; OTC Markets | Official site of the OTCQX, OTCQB and OTC Pink Marketplaces featuring Free Stock & Bond Quotes, Trade Prices, Chart, Financials and Company News & Information for Investors, Companies and Traders - OTCMarkets.com var appSection = "otcqb" ; var tierGroupId = "DQ"; var symbol = "MTNB"; var jq191 = $.noConflict(true); var appNav = new OTCMarketsAppNav(); var iqCaller = new OtcIQCalls(); var commonCaller = new PinkCommonCalls(); var contentCaller = new PinkContentCalls(); var edgarCaller = new PinkEdgarCalls(); var decorateSymbols = new SymbolDecorator(commonCaller); height="0" width="0" style="display:none;visibility:hidden"> (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= '//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer',"GTM-N65JXN"); OTC Markets Home Marketplaces Market Activity Current Market Closing Summary Broker Dealer Data Corporate Actions Short Sale Data Reg SHO Data News Company News & Financials Press Releases Videos & Presentations RSS Feeds OTC Markets Events OTC Markets Newsletter OTC Markets Press Center Services Companies Investors Market Data Trading Research Stock Screener OTCQX Company List Company Directory Service Provider Directory OTCQX Advisor List Broker Dealer Directory Prohibited Attorney List Symbology Glossary Learn Our Marketplaces Market 101 Investor Protection Reporting Requirements American Depositary Receipts (ADRs) Apply for OTCQX - Our Best Marketplace Comply with New OTCQB Requirements Information for OTC Pink Companies How to Get Traded Caveat Emptor Policy FINRA & SEC Rules Whitepapers FAQs tierTitle = getTierTitle("otcqb"); Company Directory | Stock Screener OTC Market Totals - Securities - Dollar Volume - Share Volume - Trades var glossaryDecorator = new GlossaryDecorator (contentCaller) ; $('p').each (function () { var glossaryId = $(this).attr('glossaryId'); if (glossaryId) this.psGlossaryId=glossaryId; }); if (document.getElementById('p')) glossaryDecorator .doSection (document.getElementById ('p')); $('#quoteEntry input#quoteBox').focus(function() { toggleFieldValue(this, 'Enter Symbol/Company Name', ''); }).blur(function() { toggleFieldValue(this, '', 'Enter Symbol/Company Name'); }); var security = new SecurityInfo(237581, 682078, "Matinas Biopharma Holdings, Inc.", "MATINAS BIOPHARMA HLDGS", "MTNB", "OTC Link", true, true, undefined, "Common Stock", 10, "OTCQB", false, false, true, false, undefined, undefined, undefined, false, 1.0, undefined); var symbolSecurity = (security.symbol)? security.symbol:security.secId; var initNewsId = undefined; var glossaryDecorator = new GlossaryDecorator (contentCaller) ; Quote Charts Company Profile News Financials Filings and Disclosure Short Sales Insider Disclosure Research Reports Videos and Presentations MTNB Matinas Biopharma Holdings, Inc. Common Stock SEC Reporting - Current OTCQB function doOTCQX30Logo(url) { var CONSTITUENTS_DATA; if ($.browser.msie) { var http = new XDomainRequest(); http.open("get", url); http.onload = function() { var data = http.responseText; if (typeof data === "undefined") return; CONSTITUENTS_DATA = JSON.parse(data); displayIndexLogo(CONSTITUENTS_DATA); }; http.send(null); } else { $.ajax({ type : "GET", url : url, data : {}, success : function(data) { if (typeof data === "undefined") return; CONSTITUENTS_DATA = JSON.parse(data); displayIndexLogo(CONSTITUENTS_DATA); } }); } } function displayIndexLogo(constituents) { if (typeof constituents === undefined) { if (console && console.log) { console.log("Unable to load constituents."); } } var result = $.grep(constituents, function(e){ return e.ticker == security.symbol; }); if (result.length > 0) { $('.tierLogoContainer a').attr('href', '/index/.OTCQX30/quote'); $('.tierLogo').attr('src', '/content/doc/otcm/tier/logo/small/otcqx30.png'); $('.tierLogo').attr('alt','OTCM QX ADR 30 Index Constituent'); $('.tierLogo')[0].psGlossaryId='otcqx30-constituent'; handler.decorateGlossary(); } } var json_url = "http://s3.amazonaws.com/content.otcmarkets.com/constituents/otcqx_30_list.json";; doOTCQX30Logo(json_url); var handler = new QuoteHandler(); handler.checkCaveat(); var tradeHeaderHandler; if (!window.location.href.match('quote')) tradeHeaderHandler = new TradeHeaderHandler(iqCaller, window.document.getElementById('quoteBar')); if (security.symbol == null || security.symbol.length == 0) { $('#quoteUnderArrowTabs li.eqOnly').hide(); } $('img').each(function () { var glossaryId = $(this).attr('glossaryId'); if (glossaryId) this.psGlossaryId = glossaryId; }); handler.decorateGlossary(); $("#title").html('Company Info'); var shortDesc = "Matinas BioPharma is a clinical stage biopharmaceutical company, founded in 2011, focused on the development of targeted therapeutics using our innovative lipid-based drug delivery platform with an initial focus on the treatment of serious fungal and bacterial infections and the development of lipid-based prescription therapeutics for the treatment of cardiovascular and metabolic conditions. We are focused on creating highly differentiated, safe and efficacious therapies utilizing our expertise...More >>"; var longDesc = "Matinas BioPharma is a clinical stage biopharmaceutical company, founded in 2011, focused on the development of targeted therapeutics using our innovative lipid-based drug delivery platform with an initial focus on the treatment of serious fungal and bacterial infections and the development of lipid-based prescription therapeutics for the treatment of cardiovascular and metabolic conditions. We are focused on creating highly differentiated, safe and efficacious therapies utilizing our expertise in drug formulation and development in order to address significant unmet medical needs. Recent additions to our product pipeline, including MAT2203 and MAT2501, position Matinas BioPharma to become a leader in the safe and effective delivery of anti-infective therapies utilizing its proprietary lipid-crystal nano-particle cochleate formulations. We also continue to develop our cardiovascular therapeutic candidates, with a focus on completing our ongoing PK/PD study with MAT9001, which has the goal of determining superior bioavailability and enhanced efficacy over a leading therapy for hypertriglyceridemia, as well as developing a product candidate resulting from our MAT8800 discovery program for the treatment of non-alcoholic fatty liver disease. For more information, please visit www.matinasbiopharma.comLess >>"; function toggleFullDescription(full) { if (full) { $("#businessContent p").html(longDesc); }else { $("#businessContent p").html(shortDesc); } } Company Updated Profile Contact Info 1545 Route 206 South Suite 302 Bedminster, NJ 07921 Website: http://www.matinasbiopharma.com Phone: [phone] Email: [e-mail] Find us on: Business Description toggleFullDescription(false); Financial Reporting/Disclosure Reporting Status U.S. Reporting: SEC Filer
Float: 6,366,783 a/o Mar 19, 2015
Authorized Shares: 150,000,000 a/o Mar 19, 2015
Par Value: Not Available

$MTNB extra dd links

Company name: Matinas Biopharma Holdings, Inc.
Company website: http://www.matinasbiopharma.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/MTNB/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/MTNB/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=MTNB+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=MTNB+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=MTNB+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/MTNB/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/MTNB/news - http://finance.yahoo.com/q/h?s=MTNB+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/MTNB/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/MTNB/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/MTNB/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/MTNB/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/MTNB/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/MTNB/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/MTNB/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/MTNB/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=MTNB+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/MTNB
DTCC (dtcc.com): http://search2.dtcc.com/?q=Matinas+Biopharma+Holdings%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Matinas+Biopharma+Holdings%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Matinas+Biopharma+Holdings%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.matinasbiopharma.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.matinasbiopharma.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.matinasbiopharma.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/MTNB/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/MTNB
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/MTNB/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/MTNB/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/MTNB/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001582554&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/MTNB/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/MTNB/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/MTNB/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/MTNB/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=MTNB&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=MTNB
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/MTNB/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=MTNB+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=MTNB+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=MTNB
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=MTNB
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=MTNB+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/MTNB/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=MTNB+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/MTNB.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=MTNB
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/MTNB/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/MTNB/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/MTNB/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/MTNB/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/MTNB
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/MTNB
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/MTNB:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=MTNB
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=MTNB



$MTNB DD Notes ~ http://www.ddnotesmaker.com/MTNB